Angiolab, Inc. (XKON:251280)

Angiolab Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2015	FY 2014
Period Ending	Dec 31, 2015	Dec 31, 2014
Cash & Equivalents	349.07	214.07
Short-Term Investments	2,136	3,164
Cash & Short-Term Investments	2,485	3,378
Cash Growth	-26.43%	-
Accounts Receivable	41.2	36.98
Other Receivables	7.27	45.87
Receivables	48.47	82.85
Inventory	259.07	303.19
Prepaid Expenses	0.57	1.66
Other Current Assets	23.89	12.05
Total Current Assets	2,817	3,778
Property, Plant & Equipment	18.11	16.31
Long-Term Investments	259.61	321.18
Other Intangible Assets	271.98	258.7
Long-Term Deferred Charges	990.43	1,672
Other Long-Term Assets	39.92	21.42
Total Assets	4,397	6,068
Accounts Payable	16.01	-
Accrued Expenses	41.87	20.07
Current Portion of Long-Term Debt	-	500
Other Current Liabilities	361.09	202.72
Total Current Liabilities	418.97	722.79
Long-Term Debt	-	100
Other Long-Term Liabilities	46.3	187.47
Total Liabilities	839.3	1,323
Common Stock	875.18	875.18
Additional Paid-In Capital	4,064	4,064
Retained Earnings	-1,723	-536.35
Comprehensive Income & Other	-	-0
Total Common Equity	3,216	4,403
Shareholders' Equity	3,558	4,745
Total Liabilities & Equity	4,397	6,068
Total Debt	-	600
Net Cash (Debt)	2,485	2,778
Net Cash Growth	-10.54%	-
Net Cash Per Share	2840.51	3172.31
Filing Date Shares Outstanding	0.88	0.88
Total Common Shares Outstanding	0.88	0.88
Working Capital	2,398	3,055
Book Value Per Share	3675.78	5027.28
Tangible Book Value	2,944	4,144
Tangible Book Value Per Share	3364.95	4731.89
Machinery	194.16	171.59

Source: S&P Global Market Intelligence. Standard template. Financial Sources.